1
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc, REID Scott W, May 4, 2006: WO/2006/047516 (17 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


2
Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Liu Hong, He Xiaohui, Phillips Dean, Zhu Xuefeng, Yang Kunyong, Lau Thomas, Wu Baogen, Xie Yongping, Nguyen Truc Ngoc, Wang Xing, REID Scott W, June 26, 2008: WO/2008/076754 (9 worldwide citation)

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


3
Choi Ha Soon, Wang Zhicheng, Zhu Xuefeng, He Xiaohui, Yang Kunyong, Liu Hong: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Choi Ha Soon, Wang Zhicheng, Zhu Xuefeng, He Xiaohui, Yang Kunyong, Liu Hong, RAYMOND Daniel E, September 18, 2008: WO/2008/112674 (1 worldwide citation)

The invention provides compounds of formula (I), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB 1).


4
Hong Liu, Xiaohui He, Ha Soon Choi, Kunyong Yang, David Woodmansee, Zhicheng Wang, David Archer Ellis, Baogen Wu, Yun He, Truc Ngoc Nguyen: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. IRM, Chihang Amy Smith, Genomics Institute of the Novartis Research Foundation, April 17, 2012: US08158634

The invention provides compounds having Formula Ia, or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4 and Y are as defined in the specification; as well as pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or di ...


5
Hong Liu, Xiaohui He, Dean Phillips, Xuefeng Zhu, Kunyong Yang, Thomas Lau, Baogen Wu, Yongping Xie, Truc Ngoc Nguyen, Xing Wang: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. IRM A Delaware Liability Company, Genomics Institute of the Novartis Research Foundation, Chihang Amy Smith, April 30, 2013: US08431607

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


6
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Composes et compositions servant dinhibiteurs dactivite de recepteur cannabinoide de type 1, Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Irm, Fetherstonhaugh & Co, October 25, 2011: CA2581225

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


7

8
He Xiaohui, Yang Kunyong, Liu Hong, Ellis David Archer: Composes et compositions utilises comme inhibiteurs de lactivite du recepteur cannabinoide de type 1, Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Irm, Fetherstonhaugh & Co, May 24, 2011: CA2645967

The invention provides compounds of formula (Ia), (Ic), (Ig) and (Ik), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


9
Liu Hong, He Xiaohui, Choi Ha Soon, Yang Kunyong, Woodmansee David, Wang Zhicheng, Ellis David Archer, Wu Baogen, He Yun, Nguyen Truc Ngoc: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, July 18, 2007: EP1807429-A2

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).


10
Hong Liu, Xiaohui He, Dean Phillips, Xuefeng Zhu, Kunyong Yang, Thomas Lau, Baogen Wu, Yongping Xie, Truc Ngoc Nguyen, Xing Wang: Compounds and compositions as inhibitors of cannabinoid receptor 1 activity. Irm, Genomics Institute Of The, Novartis Research Foundation, September 16, 2010: US20100234365-A1

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).